Medullary thyroid carcinoma without marked elevation of calcitonin: a diagnostic and surveillance dilemma.
暂无分享,去创建一个
S. Roman | J. Sosa | Tracy S. Wang | I. Ocal | H. Cox
[1] E. Baudin,et al. Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels. , 2007, The Journal of clinical endocrinology and metabolism.
[2] S. Larson,et al. Diagnostic Accuracy of 18F-FDG PET in Restaging Patients with Medullary Thyroid Carcinoma and Elevated Calcitonin Levels , 2007, Journal of Nuclear Medicine.
[3] A. Iagaru,et al. Detection of Occult Medullary Thyroid Cancer Recurrence with 2-Deoxy-2-[F-18]fluoro-d-glucose-PET and PET/CT , 2007, Molecular Imaging and Biology.
[4] M. Maranghi,et al. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. , 2007, The Journal of clinical endocrinology and metabolism.
[5] M. Gelos,et al. Serum calcitonin negative Medullary thyroid carcinoma , 2006, World journal of surgical oncology.
[6] S. Roman,et al. Prognosis of medullary thyroid carcinoma , 2006, Cancer.
[7] P. Dey,et al. Fine Needle Aspiration Cytology of the Thyroid , 2005, Acta Cytologica.
[8] Jonathan R. Clark,et al. Prognostic Variables and Calcitonin in Medullary Thyroid Cancer , 2005, The Laryngoscope.
[9] P. Iglesias,et al. Lack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma. , 2004, Thyroid : official journal of the American Thyroid Association.
[10] J. Plukker,et al. Impact of 18F-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography (FDG-PET) in Patients with Biochemical Evidence of Recurrent or Residual Medullary Thyroid Cancer , 2004, Annals of Surgical Oncology.
[11] O. Dirsch,et al. Lack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma. , 2004, Thyroid : official journal of the American Thyroid Association.
[12] M. Fowler,et al. Normal preoperative calcitonin levels do not always exclude medullary thyroid carcinoma in patients with large palpable thyroid masses. , 2000, Thyroid : official journal of the American Thyroid Association.
[13] H. Holzhausen,et al. Differential diagnosis of calcitonin-secreting neuroendocrine carcinoma of the foregut by pentagastrin stimulation , 2000, Langenbeck's Archives of Surgery.
[14] J. A. Wells,et al. Medullary Carcinoma of the Thyroid Gland , 2000, World Journal of Surgery.
[15] Q. Duh,et al. Medullary thyroid carcinoma , 2000, Cancer.
[16] G. Sterrett,et al. Medullary carcinoma of the thyroid , 1998, Cancer.
[17] K. Schmid,et al. ”Atypical” medullary thyroid carcinoma with little or no calcitonin expression , 1998, Virchows Archiv.
[18] W. Sturtridge,et al. Calcium infusion and pentagastrin injection in diagnosis of medullary thyroid carcinoma. , 1978, Canadian Medical Association journal.
[19] F. Singer,et al. Comparison of serum calcitonin levels after a 1-minute calcium injection and after pentagastrin injection in the diagnosis of medullary thyroid carcinoma. , 1977, The Journal of clinical endocrinology and metabolism.
[20] S. Lindsay,et al. Medullary carcinoma of the thyroid gland. , 1965, Archives of pathology.
[21] O. Gimm. Surgery for Medullary Thyroid Cancer , 2007 .
[22] E. Baudin,et al. Abnormal calcitonin basal levels and pentagastrin response in patients with chronic renal failure on maintenance hemodialysis. , 1995, European journal of endocrinology.
[23] H. Buhr,et al. Localization of occult persisting medullary thyroid carcinoma before microsurgical reoperation: high sensitivity of selective venous catheterization. , 1992, Thyroid : official journal of the American Thyroid Association.